These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D. Herlong HF; Recker RR; Maddrey WC Gastroenterology; 1982 Jul; 83(1 Pt 1):103-8. PubMed ID: 6978827 [TBL] [Abstract][Full Text] [Related]
4. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Camisasca M; Crosignani A; Battezzati PM; Albisetti W; Grandinetti G; Pietrogrande L; Biffi A; Zuin M; Podda M Hepatology; 1994 Sep; 20(3):633-7. PubMed ID: 8076921 [TBL] [Abstract][Full Text] [Related]
5. Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D. Reed JS; Meredith SC; Nemchausky BA; Rosenberg IH; Boyer JL Gastroenterology; 1980 Mar; 78(3):512-7. PubMed ID: 7351289 [TBL] [Abstract][Full Text] [Related]
6. Bone disorders in cholestatic liver diseases. Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992 [TBL] [Abstract][Full Text] [Related]
8. [Experience in treating metabolic osteopathies with 1 alpha-hydroxyvitamin D3 (oksidevit)]. Babarykin DA; Reĭsner NA; Riabukha AN; Rozental' RL Ter Arkh; 1991; 63(11):113-6. PubMed ID: 1810042 [TBL] [Abstract][Full Text] [Related]
9. Metabolic Bone Disease in Primary Biliary Cirrhosis. Glass LM; Su GL Gastroenterol Clin North Am; 2016 Jun; 45(2):333-43. PubMed ID: 27261902 [TBL] [Abstract][Full Text] [Related]
10. Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Di Bisceglie AM; Loyet M; Peters M Minerva Med; 2004 Dec; 95(6):529-34. PubMed ID: 15785437 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of 1 alpha hydroxy vitamin D3 treatment of the metabolic bone disorder in patients who underwent gastrectomy for gastric cancer. Rino Y; Imada T; Yamamoto Y; Takahashi M; Amano T; Takanashi Y Hepatogastroenterology; 2000; 47(35):1498-500. PubMed ID: 11100386 [TBL] [Abstract][Full Text] [Related]
12. [Osteodystrophy of primary biliary cirrhosis]. Guañabens Gay N; Serrano Figueras S Med Clin (Barc); 1985 Nov; 85(14):599. PubMed ID: 4079540 [No Abstract] [Full Text] [Related]
13. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Crippin JS; Jorgensen RA; Dickson ER; Lindor KD Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797 [TBL] [Abstract][Full Text] [Related]
14. Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Lindor KD Semin Liver Dis; 1993 Nov; 13(4):367-73. PubMed ID: 8303318 [TBL] [Abstract][Full Text] [Related]
16. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215 [TBL] [Abstract][Full Text] [Related]
17. Management of osteoporosis in primary biliary cirrhosis. Wolfhagen FH; van Buuren HR; Vleggaar FP; Schalm SW Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):629-41. PubMed ID: 10976019 [TBL] [Abstract][Full Text] [Related]
18. Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3. Compston JE; Crowe JP; Horton LW Br Med J; 1979 Aug; 2(6185):309. PubMed ID: 476441 [No Abstract] [Full Text] [Related]
19. Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis. Lino M; Binaut R; Noël LH; Patey N; Rustin P; Daniel L; Serpaggi J; Varaut A; Vanhille P; Knebelmann B; Grünfeld JP; Fakhouri F Am J Kidney Dis; 2005 Sep; 46(3):e41-6. PubMed ID: 16129198 [TBL] [Abstract][Full Text] [Related]
20. [Alcohol, liver, and bone involvement. Hepatic osteodystrophy]. Pumarino H Rev Med Chil; 1996 Aug; 124(8 Suppl):92-6. PubMed ID: 9197013 [No Abstract] [Full Text] [Related] [Next] [New Search]